Global | Publication | October 2018
On October 9, U.S. Customs and Border Protection (the CBP) released a Statement on Canada's Legalization of Marijuana and Crossing the Border (which can be found here). In it, the CBP advises:
A Canadian citizen working in or facilitating the proliferation of the legal marijuana industry in Canada, coming to the U.S. for reasons unrelated to the marijuana industry will generally be admissible to the U.S. However, if a traveler is found to be coming to the U.S. for reasons related to the marijuana industry, they may be deemed inadmissible.
Although this statement may provide some comfort to Canadians who are involved in the legal Canadian cannabis industry, it is important to remember that cannabis remains illegal in the U.S. at the federal level. The statement provides:
Generally, any arriving alien who is determined to be a drug abuser or addict, or who is convicted of, admits having committed, or admits committing, acts which constitute the essential elements of a violation of (or an attempt or conspiracy to violate) any law or regulation of a State, the United States, or a foreign country relating to a controlled substance, is inadmissible to the United States.
Publication
On 9 July 2025, the High Court of South Africa, Gauteng Division, Pretoria, delivered a landmark judgment in the case between the Financial Sector Conduct Authority (FSCA) and Viceroy Research Partnership LLC.
Publication
Norton Rose Fulbright provides a monthly overview of the key updates to Australian East Coast energy regulation.
Publication
In Part 1 of this series on fair use in training large language models (LLMs), we discussed Judge Alsup’s decision of Bartz v Anthropic, which found that copying books to train an LLM was fair use, but using pirated books to create a central library was not.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025